Showing results (1541-1550 of 2,361) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|November 16, 2012
A role for pharmacotherapy in the treatment of "internet addiction"Giovanni Camardese, Luisa De Risio, Marco Di Nicola, et al.Clinical Neuropharmacology|July 14, 2020
The Efficacy and Safety of Piribedil Relative to Pramipexole for the Treatment of Early Parkinson Disease: A Systematic Literature Review and Network Meta-AnalysisXianwen Chen, Cuiping Ren, Juan Li, et al.Clinical Neuropharmacology|April 26, 2021
A De Novo Missense Variant of SCN2A: Implications and Limitations for Understanding Clinical Phenotype and Treatment RecommendationsStephen I Deutsch, Jessica A BurketClinical Neuropharmacology|April 19, 2021
Functional Improvement of Tacrolimus-Induced Parkinsonism With Amantadine After Liver Transplantation: A Case ReportNicole Diaz-Segarra, Arline Edmond, Peter YonclasClinical Neuropharmacology|June 15, 2006
Effect of amantadine on depressive symptoms in chronic hepatitis C patients treated with pegylated interferon: a randomized, controlled pilot studyLucas C Quarantini, Angela Miranda-Scippa, Maria Isabel Schinoni, et al.Clinical Neuropharmacology|June 15, 2006
Reversible tremor, myoclonus, and fasciculations associated with topiramate use for migraineHortensia Alonso-Navarro, Félix Javier Jiménez-JiménezClinical Neuropharmacology|June 15, 2006
Effects of antidepressant drugs on emotionMontserrat Serra, Pilar Salgado-Pineda, Pauline Delaveau, et al.Clinical Neuropharmacology|October 1, 1991
Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic studyJ L Montastruc, O Rascol, J M Senard, et al.Clinical Neuropharmacology|December 1, 1991
Parkinson's disease: an epidemiologic method for distinguishing between symptomatic and neuroprotective treatmentsJ E RiggsClinical Neuropharmacology|December 1, 1991
A computational model of levodopa pharmacodynamics in Parkinson's diseaseP W JamiesonPageof 237